Description
TRANSGENIC INJECTION
First action · last action
2016-03-31 · 2016-07-14
Transactions
2
First transaction's obligation
$6,254
Base + all options value (sum of deltas)
$6,512
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
339113 · SURGICAL APPLIANCE AND SUPPLIES MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-03-31+$6,254= $6,254
- Mod P000012016-07-14+$258= $6,512
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-03-31 | +$6,254 | $6,254 | TRANSGENIC INJECTION |
| Mod P00001· CHANGE ORDER | 2016-07-14 | +$258 | $6,512 | TRANSGENIC INJECTION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI UNVDZNFA8R29)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24E26N0236 | RPO EAST (36C24E) · AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $1,123,416 | FY2026 |
| 36C24E25N0236 | RPO EAST (36C24E) · AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $38,324 | FY2025 |
| 36C24E25N0197 | RPO EAST (36C24E) · AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $965,353 | FY2025 |
| 36C24E24N0164 | RPO EAST (36C24E) · AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $900,820 | FY2024 |
| 36C24E24D0023 | RPO EAST (36C24E) · AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $0 | FY2024 |
| 36C10X24P0061 | SAC FREDERICK (36C10X) · R499 · SUPPORT- PROFESSIONAL: OTHER | $12,228 | FY2024 |
Other recipients under 6505 from 512-BALTIMORE(00512)(36C512) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24517F3805 | LEADIANT BIOSCIENCES, INC. | 512-BALTIMORE(00512)(36C512) | $3,859 | FY2017 |
| VA24517P3746 | MCKESSON CORPORATION | 512-BALTIMORE(00512)(36C512) | $18,959 | FY2017 |
| VA24517P3719 | BIOLOGICS, INC. | 512-BALTIMORE(00512)(36C512) | $3,865 | FY2017 |
| VA24517P1032 | MCKESSON CORPORATION | 512-BALTIMORE(00512)(36C512) | $31,073 | FY2017 |
| VA24517P3716 | EXPRESS SCRIPTS INC | 512-BALTIMORE(00512)(36C512) | $6,029 | FY2017 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24516P1780_3600_-NONE-_-NONE- · retrieved 2026-09-26.